Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

BioAegis Therapeutics

BioAegis Therapeutics
2011 FOUNDED
PRIVATE STATUS
11-20 EMPLOYEES
Series B LATEST DEAL TYPE
$4.1M LATEST DEAL AMOUNT
1 INVESTORS
Description

Developer of drugs designed to address the challenges of inflammation and infectious diseases. The company's drugs restore plasma gelsolin, a key component of innate immunity, provides an immunotherapeutic approach to fight with pathogens, enabling patients to begin treatment more quickly and result in a higher likelihood of a successful treatment.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
  • 675 US Highway One
  • Garden State Parkway, NJ 07960
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore BioAegis Therapeutics’s full profile, request a free trial.

BioAegis Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series B) 01-Aug-2018 $4.1M 000.00 000.00 Completed Clinical Trials - General
4. Grant 09-Jul-2016 00.00 000.00 Completed Clinical Trials - Phase 2
3. Angel (individual) 11-Mar-2016 00.00 000.00 0000 Completed Startup
2. Angel (individual) 01-Jan-2015 $8.04M $11M 0000 Completed Startup
1. Angel (individual) 08-Feb-2013 $3M $3M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

BioAegis Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
National Institute Of Allergy and Infectious Diseases Government 000 0000 000000 0

BioAegis Therapeutics Executive Team (14)

Name Title Board
Seat
Contact
Info
Steven Cordovano Co-Founder and Executive Corporate Development and Communications
Po-Shun Lee Founding Scientist & Scientific Advisor
Thomas Stossel MD Co-Founder, Board Member & Scientific Advisor
B. Taylor Thompson MD Clinical Advisory Board Member
John Kellum MD Clinical Advisory Board Member

1 Former Executive

You’re viewing 5 of 14 executives. Get the full list »

BioAegis Therapeutics Board Members (3)

Name Representing Role Since Contact
Info
Susan Levinson Ph.D Self Co-Founder, Board Member & Chief Executive Officer 000 0000
Thomas Stossel MD BioAegis Therapeutics Co-Founder, Board Member & Scientific Advisor 000 0000
Valerie Ceva Self Co-Founder, Board Member & Chief Operating Officer 000 0000